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Abstract Although the association between spirituality
and parameters of psychological health and disease has
been investigated extensively, little evidence is available
for its potential role in dermatology. In a single-centre
observational prospective study, 149 outpatients (107
women) with systemic sclerosis (SSc; n = 44), lupus ery-
thematosus (LE; n = 48), or early stage malignant mela-
noma (MM; n = 57) were investigated using the
multidimensional inventory for religious/spiritual well-be-
ing together with the Brief Symptom Inventory for psy-
chiatric symptoms (BSI-18). SSc patients reported the
highest amount of Somatization in comparison with LE and
MM patients (p\ 0.05). Furthermore, in line with the
previous research, spiritual dimensions, such as Hope for a
better future (p\ 0.01) or Hope for a better afterlife
(p\ 0.01), proved to be especially negatively predictive
for the global amount of psychiatric symptom burden in
these dermatological patient groups. Our findings suggest
that greater attention should be given to spiritual issues,
such as encouraging patients, imbuing them with optimism,
and offering interventions that address spiritual well-being.
Keywords Mood disorders  Lupus erythematosus 
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Introduction
In recent years, there has been a growing interest in finding
the link between religious/spiritual issues and improved
quality of life in severe illness and their expected saluto-
genic effect on well-being in this setting [15]. Accordingly,
it has been suggested that the bio-psycho-social model of
health and disease might be fruitfully augmented by con-
sidering a religious/spiritual component in handling
patients [11]. This notion, however, has also been consid-
ered speculative or its role exaggerated [17]. In any case,
the influence of the spiritual dimension in skin disease, as
being related to different parameters of mental health, is
still poorly investigated, although this area of research
seems to have great potential [8]. Religion as being related
to various parameters of mental health and illness was
prominently described as ‘‘the search for significance in
ways related to the sacred’’ (p. 11) [13]. Consequently,
spirituality, as one of the key elements of religion, was
overwhelmingly confirmed to be negatively related with
mood pathology [12]. Mood disorders as being detrimental
to quality of life, in turn, were reported in approximately
30 % of dermatology patients [1, 7]. More recently, it was
reported in a large multicentre study performed in 13
European countries that of the 3635 dermatological
patients who participated in the study, depression was
present in 10.1 %, anxiety in 17.2 %, and suicidal ideation
in 12.7 % of the cases [5].
Given this data, the purpose of the present study was to
do pioneering work in addressing the anti-depressive
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patients. We were particularly interested in finding out
which of the various dimensions of religion and spiritual-
ity, as examined by the multidimensional inventory for
religious/spiritual well-being, were related to mood
pathology and psychiatric symptoms.
Materials and methods
Study design and participants
With the expertise of authors specialising in dermatology,
we conducted a prospective single-centre observational
study with consecutive patients from the outpatient clinic
for autoimmune disease, oncology, and the day clinic at
the department of dermatology and venereology, Medical
University of Graz, between March and October 2013.
Ethics approval was obtained from the ethics committee
of the Medical University of Graz, Austria (25-280 ex12/
13). Patients with systemic sclerosis (SSc) and lupus
erythematosus (LE) (both chronic and potentially life-
threatening diseases), and those with early stages of
malignant melanoma (MM) without metastasis but with
an unknown disease course were administered question-
naires by two members (ML and SS) of our research
group and were asked to complete them after written
consent was obtained immediately after their doctor’s
appointment. The participants received no remuneration or
reward for participation. SSc was classified according to
Le Roy’s criteria [10] and LE according to the Duessel-
dorfer classification and the American College of
Rheumatology criteria (ACR) [9, 20]. MM patients had
stage I–II melanoma diagnosed by histologic criteria and
sentinel node biopsy.
Psychometric measures
The Austrian-German standardized and normed multidi-
mensional inventory of religious/spiritual well-being (MI-
RSWB) [23] measures spiritual well-being which is a
subjective phenomenon, consisting in equal measures of
existential well-being (EWB) for the immanent area of
perception, such as Hope immanent (HI), forgiveness
(FO) and experiences of sense and meaning (SM), and
religious well-being (RWB) for the transcendent area,
such as general religiosity (GR), connectedness (CO), and
hope transcendent (HT). In addition, marker items are
given as examples to illustrate the meaning of the dif-
ferent dimensions: general religiosity: ‘‘My faith gives me
a feeling of security’’; connectedness: ‘‘I have experienced
the feeling of being absorbed into something greater’’;
forgiveness: ‘‘There are things which I cannot forgive’’
(coded reversely); experiences of sense and meaning: ‘‘I
have experienced true (authentic) feelings’’; hope imma-
nent: ‘‘I view the future with optimism’’; hope transcen-
dent: ‘‘I often think about the fact that I will have to leave
behind my loved ones’’ (coded reversely). The total
amount of all six sub-scales, Religious/Spiritual Well-
Being (RSWB), has been defined as ‘‘the ability to
experience and integrate meaning and purpose in exis-
tence through a connectedness with self, others, or a
power greater than oneself’’ (p. 117) [21]. Each sub-scale
consists of six items (thus a total score of 48 items) and
has to be answered on a six-point Likert scale ranging
from 1 to 6. In the previous research, Cronbach’s a was
found to be at least 0.68 for all the sub-scales and 0.89 for
the RSWB total score [23]. A full item list for the English
version of the scale together with a short manual can be
retrieved from Unterrainer et al. [22].
The Brief Symptom Inventory-18 (BSI-18) is a short
version of the highly established Symptom Checklist SCL-
90-R [6]. The amount of psychiatric burden in three
dimensions of psychiatric symptoms (somatization,
depression, and anxiety) for the preceding 7 days is
assessed by means of 18 items (six items for each sub-
scale). The BSI-18 includes a five-point rating form rang-
ing from 1 (absolutely not) to 5 (very strong). It is also
possible to collate the 18 items into a total score: the
Global Severity Index (GSI) of psychiatric symptoms. In
the previous research, Cronbach’s a was observed to be at
least 0.79 for all the sub-dimensions and 0.91 for total
Global Severity Index score (GSI) [6].
Statistical methods
Univariate and multivariate general linear models were
conducted to investigate differences in mood pathology
between the different dermatological groups. The corre-
lation between the RSWB dimensions and mood
pathology was tested by Pearson’s correlation statistics.
For in-depth analysis, linear regression modelling was
used for those RSWB dimensions predicting the global
psychiatric symptom burden (GSI). Due to the explora-
tory nature of the study, the alpha level of significance
was set to 0.05.
Results
242 patients were recruited; 182 gave their signed consent.
33 patients were excluded due to various reasons (e.g.,
they did not return the questionnaire or did not complete
it). Thus, the data of 149 patients (107 women) with SSc
(n = 44; 37 women; age range 23–80), LE (n = 48; 41
women; age range 24–78), and MM (n = 57; 29 women;
age range 23–80) were available for the analysis. Patients
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were between 23 and 80 years of age (M = 53.50,
SD = 14.02). 107 (72 %) patients were in a relationship or
married; 42 (28 %) were single, separated, widowed, or
divorced; 114 (76.5 %) had children; 33 (22.1 %) patients
had a higher education; and 122 (81.9 %) patients were
affiliated with a religious community. These affiliations
are as follows: 112 (75.2 %) were Roman Catholic, 8
(5.4 %) were Protestant, 1 (0.7 %) was affiliated with an
alternate Christian sect, 1 (0.7 %) stated another (non-
Christian) religion and 2 (1.3 %) declined to answer the
question.
The subtypes of SSc were limited (59 %), diffuse
(16 %), undifferentiated (14 %), and primary Raynaud’s
phenomenon (11 %). Of LE patients, 71 % had cutaneous
LE and 29 % had systemic LE. Sentinel node biopsy was
performed on 62 % of MM patients, and no metastases
were detected. More detailed patient data were published in
a recent paper [14].
As shown in Table 1, we did not observe any differences
in global psychiatric symptom burden as determined by the
BSI-18 among the patient groups; however, SSc patients
exhibited a higher amount of Somatization compared to
MM patients (p\ 0.05). Compared to a group of inpatients
undergoing psychotherapy [6], our group of skin disease
patients showed, in general, a substantially lower amount
of mood pathology (p\ 0.001).
As revealed by Table 2, hope for a better future (HI;
p\ 0.01) was observed to be the strongest negative pre-
dictor of global psychiatric symptom burden (GSI). Gen-
eral religiosity (GR; p\ 0.01) and hope transcendent
(HT; p\ 0.01) showed a minor but still significant impact
on patients’ condition. Notably, there was a positive
correlation between the Connectedness dimension and
mood pathology (p\ 0.01). Overall, the assumption of a
negative correlation between RSWB and the GSI was
confirmed; however, this is mainly due to the contribution
of more existentially oriented dimensions of well-being
(EWB; p\ 0.01), while more religiously oriented
parameters (RWB) did not show any significant effect
(p[ 0.05).
Table 1 Differences in mood pathology in different skin disease groups
SSc LE MM F p g2 Post hoc
Alpha M (SD) M (SD) M (SD)
Somatization 0.79 5.18 (3.99) 4.81 (4.35) 2.77 (3.64) 3.35 \0.05 0.04 SSc[MM
Anxiety 0.83 4.59 (4.57) 4.85 (4.5) 3.42 (4.34) 0.66 n.s.
Depression 0.89 3.68 (5.02) 3.56 (4.09) 2.32 (4.18) 1.18 n.s.
Global Severity Index 0.92 13.43 (11.92) 13.21 (10.89) 8.51 (10.91) 1.92 n.s.
MANCOVA (dferror = 141; p\ 0.05) controlled for age and gender




dimensions and parameters of
mood pathology in
dermatologic patients
Somatization Anxiety Depression Global Severity Index
r b r b r b r b
SM 0.16 0.27** 0.03 0.09 0.02 0.07 0.08 0.16
HI -0.24** -0.40** -0.33** -0.38** -0.40** -0.49** -0.37** -0.48**
FO -0.15 0.01 -0.21* -0.04 -0.20* 0.01 -0.22** -0.01
HT -0.23** -0.14 -0.31** -0.27** -0.36** -0.29** -0.34** -0.27**
GR -0.04 -0.20* -0.11 -0.27** -0.04 -0.24** -0.07 -0.27**
CO 0.14 0.22* 0.12 0.28** 0.20* 0.39** 0.18* 0.34**
Corr. R2 0.17 0.24 0.35 0.33
RSWB -0.10 -0.23** -0.22** -0.21*
EWB -0.12 -0.11 -0.25** -0.23** -0.29** -0.30** -0.25** -0.25**
RWB -0.05 -0.01 -0.14 -0.06 -0.07 0.04 -0.10 -0.01
Corr. R2 0.00 0.05 0.07 0.05
Pearson correlation and beta coefficients of the linear regression model
SM experiences of sense and meaning, HI hope immanent, FO forgiveness, HT hope transcendent, GR
general religiosity, CO connectedness, RSWB religious/spiritual well-being total score, EWB existential
well-being, RWB religious well-being
* p\ 0.05; ** p\ 0.01
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Discussion
In this study, we focused on the role of spirituality and its
function in the mood stabilization of different patient
groups with severe skin diseases. Our main finding was that
all parameters of mood pathology were negatively associ-
ated with existential and, to a minor extent, with religious
well-being. Most significantly, hope immanent (for a better
future) was confirmed as being the strongest negative
correlate of mood pathology. More unexpectedly, hope
transcendent (for a better afterlife) also turned out as a
distinct predictor of more adequate adjustment to a chronic/
life-threatening skin disease. In line with the previous
findings [1], we observed an increased amount of somati-
zation in SSc compared to MM patients. This could also be
the cause of reduced physical well-being as published
recently [24]. Interestingly, we found that the dimension of
connectedness (feeling connected with the universe) was
positively related to all parameters of psychiatric symptom
burden. This is in contrast to recent research which mostly
demonstrated the salutogenic effect of the feeling of ‘‘being
connected’’ in anxious/depressive inpatients, assessed by
means of different parameters, such as sense of coherence
or more adequate coping strategies. However, in conjunc-
tion with the previous work, we assumed that feeling
connected to the universe might mirror feelings of alien-
ation and isolation from the real world in this specific
patient group [23]. In more recent studies, we could show
that patients with a skin disease exhibited a substantially
lower level of experiences of sense and meaning
(p\ 0.001) in comparison with the general population.
Patients with LE had a lower religious/spiritual well-being
(p\ 0.001), while patients with LE and MM had a lower
level of general religiosity (p\ 0.001) and religious well-
being (p\ 0.001). By contrast, MM patients exhibited a
higher level of forgiveness (p\ 0.01) and hope transcen-
dent (p\ 0.01) and a lower level of connectedness
(p\ 0.001). No differences were found for hope immanent
and the amount of existential well-being in skin disease
patients compared to the general population [24].
In line with the previous research [23], we conclude
that our initial results, concerning different groups of
patients with severe skin conditions, confirm the hypoth-
esis that there exists a high therapeutic potential of the
spiritual dimension in clinical treatment. However, these
results still have to be confirmed by employing larger
samples incorporating centres in other countries and dif-
ferent dermatologic patient groups, such as metastasizing
melanoma, psoriasis, or atopic dermatitis. Further studies
might also consider the fact that other variables, such as
personality traits, could mediate or moderate the correla-
tions in addition to poor QoL that might have also
influenced the outcome of the current study in SSc and LE
patients [3]. Therefore, more research is needed to make a
more general statement about the role of spirituality in
skin diseases. The dimension of hope, especially, seems to
be of central relevance for the mood stability of patients
dealing with these severe skin diseases. Further research
might focus now on the development of spiritually inte-
grated therapeutic interventions, such as supplying
patients, with hope or discussing existential questions as a
potential treatment for dermatological patients [2]. In fact,
there is already a lot of literature on how to integrate
spiritual dimensions, such as hope or sense, of meaning
most effectively into patient treatment [19]. Hope therapy
[18] was reported to increase some psychological
strengths and reduce some symptoms of psychopathology
[4]. Furthermore, the core-dimension of existential ther-
apy [16] of finding a meaning in life for psychological
well-being can be found prominently discussed in the
literature [25].
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